BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2787454)

  • 21. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
    Gajewski TF; Fitch FW
    J Immunol; 1988 Jun; 140(12):4245-52. PubMed ID: 2967332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
    Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT; Grant AJ; Siegel JP
    J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of interleukin 2 in the regulation of proliferation and IgM synthesis of human newborn mononuclear cells.
    Punnonen J
    Clin Exp Immunol; 1989 Mar; 75(3):421-6. PubMed ID: 2784745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
    Kupper T; Horowitz M; Lee F; Robb R; Flood PM
    J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
    Murakawa Y; Strober W; James SP
    J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiotypic immunoglobulin secretion by human B cell non-Hodgkin's lymphomas is related to the expression of the interleukin-2 receptor.
    Vyth-Dreese FA; Dellemijn TA; Hekman A; Melief CJ
    Leukemia; 1988 Apr; 2(4):231-5. PubMed ID: 3129622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
    Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
    Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukemic cells from progressive B-CLL respond strongly to growth stimulation in vitro.
    Aguilar-Santelises M; Mellstedt H; Jondal M
    Leukemia; 1994 Jul; 8(7):1146-52. PubMed ID: 8035606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC; Davis LS; Lipsky PE
    J Immunol; 1989 Mar; 142(5):1548-57. PubMed ID: 2783946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-12 stimulates B cell growth by inducing IFN-gamma.
    Li L; Young D; Wolf SF; Choi YS
    Cell Immunol; 1996 Mar; 168(2):133-40. PubMed ID: 8640858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
    Engel P; Inglés J; de la Calle O; Gallart T
    Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic and antagonistic effects of IL-1 alpha and IL-4, respectively, on the IL-2-dependent growth of a T cell receptor-gamma delta+ human T leukemia cell line.
    Santoli D; O'Connor R; Cesano A; Phillips P; Colt TL; Lange B; Clark SC; Rovera G
    J Immunol; 1990 Jun; 144(12):4703-11. PubMed ID: 2351825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
    Defrance T; Vanbervliet B; Aubry JP; Banchereau J
    J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory effects of IL-4 on human B-cell response to IL-2.
    Galanaud P; Karray S; Llorente L
    Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells.
    Beagley KW; Eldridge JH; Kiyono H; Everson MP; Koopman WJ; Honjo T; McGhee JR
    J Immunol; 1988 Sep; 141(6):2035-42. PubMed ID: 3262647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human recombinant IL-3 is a growth factor for normal B cells.
    Xia X; Li L; Choi YS
    J Immunol; 1992 Jan; 148(2):491-7. PubMed ID: 1729368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.